نتایج جستجو برای: tau

تعداد نتایج: 20923  

Journal: :Journal of neuropathology and experimental neurology 2008
Gustavo Basurto-Islas Jose Luna-Muñoz Angela L Guillozet-Bongaarts Lester I Binder Raul Mena Francisco García-Sierra

Truncations of tau protein at aspartic acid421 (D421) and glutamic acid391 (E391) residues are associated with neurofibrillary tangles (NFTs) in the brains of Alzheimer disease (AD) patients. Using immunohistochemistry with antibodies to D421- and E391-truncated tau (Tau-C3 and MN423, respectively), we correlated the presence of NFTs composed of these truncated tau proteins with clinical and ne...

Journal: :Neurobiology of aging 2010
Liana G Apostolova Kristy S Hwang John P Andrawis Amity E Green Sona Babakchanian Jonathan H Morra Jeffrey L Cummings Arthur W Toga John Q Trojanowski Leslie M Shaw Clifford R Jack Ronald C Petersen Paul S Aisen William J Jagust Robert A Koeppe Chester A Mathis Michael W Weiner Paul M Thompson

Cerebrospinal fluid (CSF) measures of Ab and tau, Pittsburgh Compound B (PIB) imaging and hippocampal atrophy are promising Alzheimer's disease biomarkers yet the associations between them are not known. We applied a validated, automated hippocampal labeling method and 3D radial distance mapping to the 1.5T structural magnetic resonance imaging (MRI) data of 388 ADNI subjects with baseline CSF ...

2014
Yunpeng Huang Zhihao Wu Yu Cao Minglin Lang Bingwei Lu Bing Zhou

Tau hyperphosphorylation is thought to underlie tauopathy. Working in a Drosophila tauopathy model expressing a human Tau mutant (hTauR406W, or Tau(∗)), we show that zinc contributes to the development of Tau toxicity through two independent actions: by increasing Tau phosphorylation and, more significantly, by directly binding to Tau. Elimination of zinc binding through amino acid substitution...

2015
Sethu Sankaranarayanan Donna M. Barten Laurel Vana Nino Devidze Ling Yang Gregory Cadelina Nina Hoque Lynn DeCarr Stefanie Keenan Alan Lin Yang Cao Bradley Snyder Bin Zhang Magdalena Nitla Gregg Hirschfeld Nestor Barrezueta Craig Polson Paul Wes Vangipuram S. Rangan Angela Cacace Charles F. Albright Jere Meredith John Q. Trojanowski Virginia M-Y. Lee Kurt R. Brunden Michael Ahlijanian

In Alzheimer's disease (AD), an extensive accumulation of extracellular amyloid plaques and intraneuronal tau tangles, along with neuronal loss, is evident in distinct brain regions. Staging of tau pathology by postmortem analysis of AD subjects suggests a sequence of initiation and subsequent spread of neurofibrillary tau tangles along defined brain anatomical pathways. Further, the severity o...

Journal: :Biophysical journal 2017
Xiao-Han Li Elizabeth Rhoades

Tau is an intrinsically disordered protein with a central role in the pathology of a number of neurodegenerative diseases. Tau normally functions to stabilize neuronal microtubules, although the mechanism underlying this function is not well understood. Of note is that the interaction between tau and soluble tubulin, which has implications both in understanding tau function as well as its role ...

Journal: :Biomolecules 2016
Ryuichi Harada Nobuyuki Okamura Shozo Furumoto Tetsuro Tago Kazuhiko Yanai Hiroyuki Arai Yukitsuka Kudo

Tau deposition is one of the neuropathological hallmarks in Alzheimer's disease as well as in other neurodegenerative disorders called tauopathies. Recent efforts to develop selective tau radiopharmaceuticals have allowed the visualization of tau deposits in vivo. In vivo tau imaging allows the assessment of the regional distribution of tau deposits in a single human subject over time for deter...

Journal: :The Journal of biological chemistry 2011
Umesh K Jinwal Justin H Trotter Jose F Abisambra John Koren Lisa Y Lawson Grant D Vestal John C O'Leary Amelia G Johnson Ying Jin Jeffrey R Jones Qingyou Li Edwin J Weeber Chad A Dickey

The microtubule-associated protein tau, which becomes hyperphosphorylated and pathologically aggregates in a number of these diseases, is extremely sensitive to manipulations of chaperone signaling. For example, Hsp90 inhibitors can reduce the levels of tau in transgenic mouse models of tauopathy. Because of this, we hypothesized that a number of Hsp90 accessory proteins, termed co-chaperones, ...

Journal: :Journal of Alzheimer's disease : JAD 2015
Laiq-Jan Saidi Manuela Polydoro Kevin R Kay Laura Sanchez Eva-Maria Mandelkow Bradley T Hyman Tara L Spires-Jones

One of the hallmarks of Alzheimer's disease is the formation of neurofibrillary tangles, intracellular aggregates of hyperphosphorylated, mislocalized tau protein, which are associated with neuronal loss. Changes in tau are known to impair cellular transport (including that of mitochondria) and are associated with cell death in cell culture and mouse models of tauopathy. Thus clearing pathologi...

Journal: :International journal of clinical and experimental pathology 2011
Samuel S Yen

The proteasomal degradation of cytosolic, phosphorylation-independent tau in human brains is potentially linked to the pathogenesis of neurofibrillary pathology in Alzheimer's disease (AD). Previous studies showed that the active 20S proteasome core degrades recombinant tau effectively, which prompted this study to determine if there was evidence of proteasomal degradation of tau in human brain...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Hong-Bin Luo Yi-Yuan Xia Xi-Ji Shu Zan-Chao Liu Ye Feng Xing-Hua Liu Guang Yu Gang Yin Yan-Si Xiong Kuan Zeng Jun Jiang Keqiang Ye Xiao-Chuan Wang Jian-Zhi Wang

Intracellular accumulation of the abnormally modified tau is hallmark pathology of Alzheimer's disease (AD), but the mechanism leading to tau aggregation is not fully characterized. Here, we studied the effects of tau SUMOylation on its phosphorylation, ubiquitination, and degradation. We show that tau SUMOylation induces tau hyperphosphorylation at multiple AD-associated sites, whereas site-sp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید